B. Lehmann et al., HUMAN KERATINOCYTE LINE HACAT METABOLIZES 1-ALPHA-HYDROXYVITAMIN D-3 AND VITAMIN-D-3 TO 1-ALPHA,25-DIHYDROXYVITAMIN D-3 (CALCITRIOL), Journal of dermatological science, 18(2), 1998, pp. 118-127
Cultured human keratinocytes have the property to hydroxylate exogenou
s 25-hydroxyvitamin D-3 (25OHD(3)) at the C-1 alpha position thus prod
ucing 1 alpha,25-dihydroxyvitamin D-3 (1 alpha,25(OH)(2)D-3). In this
study we investigated whether keratinocytes can also hydroxylate vitam
in D-3 and one of its metabolites at the C-25 position. We could demon
strate that HaCaT keratinocytes can metabolize 1 alpha-hydroxyvitamin
D-3 (1 alpha-OHD3) and vitamin D-3 to 1 alpha,25(OH)(2)D-3. Identifica
tion of the generated product as 1 alpha,25(OH)(2)D-3 was based on its
elution pattern in two different high performance liquid chromatograp
hy systems, on its specific binding in a calf thymus receptor assay an
d on its gas chromatography-mass spectrometry characteristics. The hyd
roxylation of vitamin D-3 to 1 alpha,25(OH)(2)D-3 was dose- and time-d
ependent. Bovine serum albumin added up to 1.5% (w/v) to the culture m
edium greatly increased the hydroxylation rates. These results show th
at HaCaT cells have the capacity to hydroxylate vitamin D-3 at the C-1
/25 positions. The generation of endogenous 1 alpha,25(OH)(2)D-3 from
vitamin D-3 within the skin may indicate a novel pathway which is of i
mportance for the regulation of epidermal cell growth and differentiat
ion. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.